← Back to All Filings

Guardant Health Director Vests RSUs, Acquires 154 Shares

Low SignificanceNovember 3, 2025 at 6:03:12 PM EST

Guardant Health, Inc.

$GH4CIK: 0001576280

Subscribe to track GH

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Guardant Health Director Vests RSUs

Company: Guardant Health, Inc. (GH) Form: 4 | Filed: 2025-11-03 Significance: Low

Insider: Krognes Steve E. Title: null | Relationship: Director

Transaction: • Type: RSU Vesting • Shares: 154 • Price: $0.00 • Value: $0 • Owned After: 18,436

Key Insight: A director acquired a small number of shares through the routine vesting of a previously granted restricted stock unit award.

Market Context: The transaction is non-discretionary and has no market value, representing a negligible 0.00012% of the company's outstanding shares.

Comprehensive Analysis

SEC Filing Analysis: Guardant Health, Inc. (GH)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A director acquired 154 shares of common stock through the routine vesting of a Restricted Stock Unit (RSU) award, a non-market transaction with no cash value.
  • Market Impact: Neutral. This is a pre-scheduled event and does not reflect new insider sentiment.

Company Information

FieldValue
CompanyGuardant Health, Inc.
Ticker SymbolGH
CIK0001576280
IndustrySERVICES-MEDICAL LABORATORIES

Insider Information

FieldValue
NameKrognes Steve E.
CIK0001666236
Title/Positionnull
RelationshipDirector

Transaction Details

FieldValue
Form Type4
Transaction Date2025-10-31
Transaction CodeM (Exercise/Conversion of derivative security)
Security TypeCommon Stock
Shares Involved154
Price Per Share$0.00
Total Value$0
Shares Owned After18,436
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.00%
Shares Transacted154
% of Shares Outstanding0.00012%
Post-Transaction Ownership18,436 shares (0.015% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The transaction has a $0 value and is immaterial against the company's $11.72 billion market capitalization.
  • Ownership Concentration: The director's post-transaction ownership of 0.015% is not a significant concentration of shares.
  • Dilution Impact: The vesting of 154 shares represents a negligible 0.00012% of shares outstanding and has no meaningful dilutive effect on existing shareholders.
  • Transaction Significance: The transaction is a routine, non-discretionary vesting of RSUs and carries no new market signal or investment thesis.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: This is a non-market, pre-planned transaction with zero cash value, indicating no change in insider sentiment or new information.

Volume & Sentiment

  • Expected Volume Impact: None. The transaction is a transfer of equity as compensation, not an open market trade.
  • Sentiment Indicator: Neutral. The event is a routine part of an executive compensation plan.

Additional Context

Transaction Notes

  • Special Circumstances: The transaction represents the vesting of a portion of an RSU award granted on August 9, 2022. This is a scheduled event, not a discretionary trade.
Topics:#SECFiling#InsiderTrading#Form4#GuardantHealth#GH#RSU#StockMarket#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.